PDE4 Inhibitors and the Treatment Toolbox for AD

What do topical PDE4 inhibitors bring to the treatment toolbox? Which patients are likely to get the most use out of them? Robert Sidbury, MD, MPH, answers these questions and more in this video interview.

Robert Sidbury, MD, MPH, the division chief of dermatology at Seattle Childrens, expands on his presentation from the 4th annual Revolutionizing Atopic Dermatitis (RAD) conference being held from April 9 to 11 in Baltimore, Maryland.